SAVA
: SAVA
$1.70-0.05 (-2.86%)Closed
Market Cap—
Cash—most recent
Runway—
P/E (TTM)—
52-Wk Range$1.51 – $4.64
Avg Volume1.3M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$1.70-91.7%
Pipeline
Drug candidates sponsored by SAVA · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for SAVA. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.